Welcome to our dedicated page for Cadre Hldgs SEC filings (Ticker: CDRE), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Cadre Holdings, Inc. SEC filings document the company's safety-equipment business, public-company governance and NYSE-listed common stock. Form 8-K reports cover operating results, financial condition, Regulation FD presentations, material events and related exhibits for its law enforcement, first responder, military and nuclear safety markets.
Cadre's filings also include proxy materials for annual meeting matters, board and stockholder voting procedures, and corporate governance disclosures. Financial-result filings discuss GAAP measures alongside non-GAAP metrics such as EBITDA, adjusted EBITDA and adjusted EBITDA margin, while event reports address material agreements, acquisition-related communications, capital-structure disclosures and security registration details for CDRE common stock.
Cadre Holdings, Inc. director Mary E. Kissel received a grant of stock options for 17,393 shares of common stock. The options have an exercise price of $28.75 per share and expire on June 16, 2036, functioning as equity-based compensation rather than an open-market purchase.
These options were granted under the company’s 2021 Stock Incentive Plan. They vest in four installments: 4,349 shares on June 30, 2026, and 4,348 shares on each of September 30, 2026, December 31, 2026, and March 31, 2027. All holdings reported are direct.
Cadre Holdings director William G. Quigley III received a grant of stock options for 17,393 shares of common stock at an exercise price of $28.75 per share. The options were granted under Cadre’s 2021 Stock Incentive Plan as equity-based compensation.
These options vest in four installments: options to purchase 4,349 shares vest and become exercisable on June 30, 2026, and options to purchase 4,348 shares vest and become exercisable on each of September 30, 2026, December 31, 2026, and March 31, 2027. Any unexercised options expire on June 16, 2036.
Cadre Holdings, Inc. large shareholder Warren B. Kanders filed an amended Schedule 13D reporting beneficial ownership of 11,392,928 common shares, or about 26.4% of the company. This total includes 9,692,039 shares held by Kanders SAF, options for 348,901 shares that are currently exercisable within 60 days, and 1,329,100 shares held through Roth IRAs for Mr. and Mrs. Kanders.
The filing notes that 3,750,000 of the beneficially owned shares are subject to a security interest in favor of Texas Capital Bank under a loan agreement. Kanders SAF separately reports beneficial ownership of 9,692,039 shares, representing about 22.6% of the outstanding common stock.
The amendment also discloses recent open-market sales by Kanders SAF: 100,000 shares on June 15, 2026 at a weighted average price of $30.03 per share, 100,000 shares on June 16, 2026 at $28.19 per share, and 25,000 shares on June 17, 2026 at $28.68 per share.
Cadre Holdings, Inc. reported that director Hamish Norton received a grant of stock options to purchase 17,393 shares of common stock at an exercise price of $28.75 per share under the company’s 2021 Stock Incentive Plan. The options expire on June 16, 2036 and vest in four installments between June 30, 2026 and March 31, 2027.
Cadre Holdings director Nicolas Sokolow received a grant of stock options to buy 17,393 shares of common stock at an exercise price of $28.75 per share. These options expire on June 16, 2036 and were issued under the company’s 2021 Stock Incentive Plan.
According to the vesting schedule, options for 4,349 shares will vest and become exercisable on June 30, 2026. Additional tranches of 4,348 options will vest and become exercisable on each of September 30, 2026, December 31, 2026, and March 31, 2027.
Cadre Holdings, Inc. reported new equity awards for its Chief Financial Officer, Blaine Browers. He received stock options for 115,000 and 92,500 shares of common stock at an exercise price of $28.75 per share, along with restricted stock unit awards covering 69,500 and 48,500 shares.
All four grants are performance-based. The RSUs vest only if the common stock reaches a volume-weighted average price of at least $60.00 or $80.00 per share, depending on the tranche, over a 20 consecutive trading day period on or before June 16, 2033, and then only after the third anniversary of grant. The options have similar VWAP hurdles of $60.00 and $80.00 per share and become exercisable on the later of meeting those conditions and the third anniversary.
Cadre Holdings, Inc. reported that President Brad Williams received new equity awards tied to future stock performance. On June 16, 2026, he was granted stock options for 136,000 and 109,500 shares of common stock at an exercise price of $28.75 per share, expiring on June 16, 2033. He also received 82,000 and 57,500 restricted stock units. All four awards vest only if, on or before June 16, 2033, Cadre’s stock reaches a volume-weighted average price of at least $60 or $80 per share over 20 consecutive trading days, and then only after at least three years have passed from the grant date.
Cadre Holdings CEO and chairman Warren B. Kanders received significant performance-based equity awards in the form of stock options and restricted stock units. On the reported date, he was granted options to purchase 496,500 and 616,500 shares of common stock at an exercise price of $28.75 per share, and 261,000 and 373,000 restricted stock units.
All awards vest only if, on or before June 16, 2033, Cadre’s stock reaches specified volume-weighted average price targets of $60 or $80 per share over a 20-day period. These are compensation grants, not open-market share purchases or sales.
Cadre Holdings, Inc. director, CEO and chairman Warren B. Kanders reported that Kanders SAF, LLC, an entity he manages, sold a total of 225,000 shares of Cadre common stock in open-market transactions on June 15–17, 2026.
The LLC sold 100,000 shares at a weighted average price of $30.03 on June 15, 100,000 shares at $28.19 on June 16, and 25,000 shares at $28.68 on June 17, across multiple trades each day. After these sales, Kanders SAF, LLC held 9,692,039 shares of Cadre common stock.
The filing also lists other indirect holdings, including 1,305,650 shares held by a Roth IRA for Warren B. Kanders and 23,450 shares held by a Roth IRA for his spouse, plus 22,888 shares held directly. Kanders disclaims beneficial ownership of certain securities except to the extent of his pecuniary interest.
Warren B. Kanders reported sales of Common Stock under Rule 144. The filing lists two transactions: 100,000 shares sold on 03/20/2026 for $3,140,000 and 100,000 shares sold on 03/23/2026 for $3,193,000. The record also includes a liquidating distribution tied to Maui Holdings LLC dated 12/07/2021 for 15,866,703 shares as shown in the excerpt.